Literature DB >> 12164379

Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy.

Christophe Rousselle1, Philippe Clair, Jamal Temsamani, Jean-Michel Scherrmann.   

Abstract

Previous studies from our laboratory have demonstrated that the coupling of doxorubicin with SynB1 vector dramatically increases its brain uptake. In the present study, we have evaluated the broad application of this approach using another molecule: benzylpenicillin (B-Pc). We, therefore, have coupled the beta-lactam antibiotic B-Pc with SynB1 and assessed its ability to cross the blood-brain barrier (BBB) using the in situ rat brain perfusion method. We first confirmed the very low brain uptake of free radiolabeled B-Pc. When B-Pc was coupled to SynB1, its uptake in brain was increased by a factor of 7, without compromising the BBB integrity. The vectorised B-Pc was distributed in all the gray areas assessed (frontal, parietal, and occipital cortex, thalamus, hippocampus, and striatum). Moreover, using a wash-out procedure and a capillary depletion method, we have shown that the radiolabeled B-Pc was associated mainly with brain parenchyma. In summary, this study demonstrates the successful application of the use of SynB1 vector for the transport of B-Pc across the BBB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164379     DOI: 10.1080/10611860290031886

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  15 in total

1.  Peptides containing antigenic and cationic domains have enhanced, multivalent immunogenicity when bound to DNA vaccines.

Authors:  Petra Riedl; Jörg Reimann; Reinhold Schirmbeck
Journal:  J Mol Med (Berl)       Date:  2003-12-02       Impact factor: 4.599

Review 2.  Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.

Authors:  Guillaume Drin; Christophe Rousselle; Jean-Michel Scherrmann; Anthony R Rees; Jamal Temsamani
Journal:  AAPS PharmSci       Date:  2002

Review 3.  Tumor targeting peptides: novel therapeutic strategies in glioblastoma.

Authors:  Drazen Raucher
Journal:  Curr Opin Pharmacol       Date:  2019-02-15       Impact factor: 5.547

Review 4.  Peptides as targeting elements and tissue penetration devices for nanoparticles.

Authors:  Erkki Ruoslahti
Journal:  Adv Mater       Date:  2012-05-02       Impact factor: 30.849

Review 5.  Molecular photoswitches in aqueous environments.

Authors:  Jana Volarić; Wiktor Szymanski; Nadja A Simeth; Ben L Feringa
Journal:  Chem Soc Rev       Date:  2021-11-15       Impact factor: 54.564

Review 6.  CNS delivery via adsorptive transcytosis.

Authors:  Françoise Hervé; Nicolae Ghinea; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2008-08-26       Impact factor: 4.009

7.  Peptides as drug delivery vehicles across biological barriers.

Authors:  Debadyuti Ghosh; Xiujuan Peng; Jasmim Leal; Rashmi Mohanty
Journal:  J Pharm Investig       Date:  2017-12-12

8.  Efficient LRP1-Mediated Uptake and Low Cytotoxicity of Peptide L57 In Vitro Shows Its Promise as CNS Drug Delivery Vector.

Authors:  Jolin P Rodrigues; Neela Prajapati; Mark A DeCoster; Scott Poh; Teresa A Murray
Journal:  J Pharm Sci       Date:  2020-10-14       Impact factor: 3.534

9.  dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Sangho Lim; Won-Ju Kim; Yeon-Ho Kim; Sohee Lee; Ja-Hyun Koo; Jung-Ah Lee; Heeseok Yoon; Do-Hyun Kim; Hong-Jai Park; Hye-Mi Kim; Hong-Gyun Lee; Ji Yun Kim; Jae-Ung Lee; Jae Hun Shin; Lark Kyun Kim; Junsang Doh; Hongtae Kim; Sang-Kyou Lee; Alfred L M Bothwell; Minah Suh; Je-Min Choi
Journal:  Nat Commun       Date:  2015-09-15       Impact factor: 14.919

10.  Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.

Authors:  Yangfang Li; Qian Wu; Chen Li; Ling Liu; Kun Du; Jin Shen; Yuqin Wu; Xiaofen Zhao; Mei Zhao; Lingyun Bao; Jin Gao; Richard F Keep; Jianming Xiang
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.